Expert Insights
ETF Channels
ETF Strategist
Multi-Asset
Smart Beta
Tactical Allocation
Thematic Investing
Alternatives
Leveraged & Inverse
Disruptive Technology
Innovative ETFs
Equity ETF
Retirement Income
Crypto
ETF Building Blocks
Nasdaq Portfolio Solutions
Model Portfolio
Active ETF
ESG
Entrepreneur ETF
ETF 360
Webcasts
Popular ETFs
SPY – SPDR S&P 500 ETF
VOO – Vanguard S&P 500 ETF
QQQ – Invesco QQQ ETF
GLD – SPDR Gold Shares ETF
IVV – iShares Core S&P 500 ETF
EFA – iShares MSCI EAFE ETF
EEM – iShares MSCI Emerging Markets ETF
IEMG – iShares Core MSCI Emerging Markets ETF
VTI – Vanguard Total Stock Market ETF
GDX – VanEck Vectors Gold Miners ETF
XLF – Financial Select Sector SPDR Fund
VEA – Vanguard FTSE Developed Markets ETF
VTV – Vanguard Value ETF
Top Gold ETFs
Top Oil ETFs
Top Commodity ETFs
Top Hedge Fund ETFs
Top Financials ETFs
Top Inverse Equities ETFs
Top High Yield Bond ETFs
ETF Education
Newsletter
New ETFs
ETF Ecosystem
Education Central
Video
Podcasts
ETF Playbook
Virtual Summit
BBH
Featured
The Emergency Room ETF Could Soar Again in 2014
By
Tom Lydon
December 17, 2013
Equity ETFs
Some of 2012’s Best Sector ETFs Kept Soaring in 2013
By
Tom Lydon
December 10, 2013
Featured
Biotech ETFs: More Tricks Than Treats in October
By
Max Chen
October 31, 2013
Featured
Biotech ETFs Look to Claw Back After Shutdown Slump
By
Todd Shriber
October 22, 2013
Featured
Triple-Digit Divas Reside in These ETFs
By
Todd Shriber
October 18, 2013
Featured
Sell-Off in Biotech ETFs Could Be a Temporary Setback
By
Tom Lydon
October 10, 2013
Featured
10 ETF Investments That Got the Most Bang for Your Buck
By
Tom Lydon
October 8, 2013
Featured
ETF Categories That Just Keep On Winning
By
Gary Gordon
October 2, 2013
Featured
Three ETFs to Play the Outperforming Biotech Sector
By
Tom Lydon
August 19, 2013
Featured
Investors Clamor for Generic Drug ETF
By
Tom Lydon
May 6, 2013
Featured
Ups and Downs for ETFs in 2012
By
Tom Lydon
December 31, 2012
Featured
Why Biotech ETFs are a Top Sector in 2012
By
Tom Lydon
December 19, 2012
Featured
More M&A Deals Could Boost Biotech ETFs
By
Tom Lydon
December 11, 2012
Featured
Biotech ETFs Holding Up During Rocky November
By
Tom Lydon
November 19, 2012
Featured
Biotech ETFs Cool After Strong Run
By
Tom Lydon
August 13, 2012
Featured
Biotech ETFs Weather Market Storm
By
John Spence
May 14, 2012
Featured
Natural Gas ETF Rebound Continues with 9% Weekly Advance
By
Tom Lydon
May 12, 2012
Featured
Choosing the Right Biotech ETF Exposure
By
Tom Lydon
April 20, 2012
Previous
1
…
3
4
5
6
7
Next
X